Ultrasonics Sonochemistry · 2024 · 14 citations · 18 references
MedicineImmunologyOncologyImmunoregulationImmunotherapyTumor MicroenvironmentCancer ImmunotherapyContrast-enhanced UltrasoundHypoxia AdaptationImmunotherapy For Solid TumorsTumor Immune MicroenvironmentTumor Microenvironment ModulationHypoxia-driven ImmunosuppressionImmunosuppressive MicroenvironmentPd-l1 BlockadeTumor Microenvironment HypoxiaTumor Microenvironment RegulationTumor OxygenationTumor Vascular NormalizationTumor Vasculature Normalization
• Sononeoperfusion refers to tumor perfusion enhancement by ultrasound stimulated microbubble cavitation. • Sononeoperfusion is a promising method to alleviate tumor hypoxia and immunosuppression. • The mechanism by which sononeoperfusion modulates the tumor immune microenvironment may be associated with the induction of tumor vascular normalization. • Sononeoperfusion way can be easily translated to clinic for facilitating immunotherapy. The hypoxic and immunosuppressive tumor microenvironment (TME) remains a major obstacle to impede cancer immunotherapy. Here, we found that sononeoperfusion—a new effect of tumor perfusion enhancement induced by low mechanical index ultrasound stimulated microbubble cavitation (USMC)—ameliorated tumor tissue oxygenation and induced tumor vascular normalization (TVN). This TVN might be associated with the down-regulation of hypoxia-inducible factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF) within tumors. Moreover, the sononeoperfusion effect reduced the accumulation of immunosuppressive cells, such as regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs) and M2-like tumor-associated macrophages (M2-TAMs), and decreased the production of immune inhibitory factors like transforming growth factor-β1 (TGF-β1), interleukin 10 (IL-10), chemoattractant chemokines CC-chemokine ligand 22 (CCL22), CCL28, adenosine and lactate within tumors. Notably, flow cytometry analysis revealed that sononeoperfusion not only increased the percentage of tumor infiltrating-CD8 + T cells, but also promoted the generation of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) by these cells. Furthermore, the improved immune TME by sononeoperfusion effect sensitized anti-PD-L1 treatment both in MC38 colon cancer and Lewis lung carcinoma mice, resulting in tumor regression and prolonged survival. Mechanically, the enhanced efficacy of combination therapy was mainly based on promoting the infiltration and function of CD8 + T cells within tumors. Together, sononeoperfusion could ameliorate hypoxia and immunosuppression in the TME, thereby potentiating anti-PD-L1 therapy for solid tumors. This novel method of USMC generating sononeoperfusion effect may provide a new therapeutic modality for facilitating cancer immunotherapy.
18
Hallmarks of Cancer: New Dimensions
Cancer Discovery · 2022 · 9.1K citations · Full text
Medicine, Cancer Biology, Oncology +17
Photodynamic therapy for hypoxic tumors: Advances and perspectives
Huang Li, Shaojing Zhao, Jiasheng Wu et al. · Coordination Chemistry Reviews · 2021 · 357 citations
Medicine, Cancer Biology, Oncology +13
Low temperature photothermal therapy: Advances and perspectives
Ke Yang, Shaojing Zhao, Baoling Li et al. · Coordination Chemistry Reviews · 2021 · 297 citations
Tumor Microenvironment, Metabolism, and Immunotherapy
Ralph J. DeBerardinis · New England Journal of Medicine · 2020 · 294 citations
Medicine, Immunology, Oncology +17
Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance
Heng Lin, Ilona Kryczek, Shasha Li et al. · Cancer Cell · 2021 · 156 citations · Full text
Medicine, Cancer Biology, Immunology +16